Stock Research: Innoviva

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

Innoviva

NasdaqGS:INVA US45781M1018
93
  • Value
    91
  • Growth
    75
  • Safety
    Safety
    37
  • Combined
    91
  • Sentiment
    86
  • 360° View
    360° View
    93
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Innoviva, Inc. is a diversified holding company focused on healthcare assets. It operates in the healthcare industry, with a portfolio of respiratory assets partnered with Glaxo Group Limited (GSK), including RELVAR/BREO ELLIPTA and ANORO ELLIPTA. It also has products like GIAPREZA and XERAVA. The company is based in the United States. In the last fiscal year, the company had a market cap of $1,257 million, profits of $322 million, revenue of $359 million, and 127 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 93 (better than 93% compared with alternatives) for 2025, overall professional sentiment and financial characteristics for the stock Innoviva are very positive. The 360° View is based on consolidating four consolidated indicators, with all but one indicator above average for Innoviva. The consolidated Growth Rank has a good rank of 75, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. This means that growth is higher than for 75% of competitors in the same industry. The consolidated Safety Rank at 91 means that the company has a financing structure that is safer than 91% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. Finally, the consolidated Sentiment Rank has a good rank of 86, which means that professional investors are more optimistic about the stock than for 86% of alternative investment opportunities. But the consolidated Value Rank is less desirable at 37, meaning that the share price of Innoviva is on the higher side compared with indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 63% of alternative stocks in the same industry. ...read more

more
Index
NASDAQ
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 21-Aug-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Growth
Shows a company's growth potential.
High Growth Tough Times
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
37 43 14 53
Growth
75 31 57 21
Safety
Safety
91 57 60 87
Sentiment
86 36 29 61
360° View
360° View
93 23 21 63
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
91 15 1 2
Opinions Change
82 50 50 50
Pro Holdings
n/a 86 98 98
Market Pulse
23 31 20 60
Sentiment
86 36 29 61
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
37 43 14 53
Growth
75 31 57 21
Safety Safety
91 57 60 87
Combined
91 25 31 64
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
66 70 50 89
Price vs. Earnings (P/E)
38 34 24 20
Price vs. Book (P/B)
45 45 41 64
Dividend Yield
1 1 1 1
Value
37 43 14 53
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
68 17 49 9
Profit Growth
98 8 15 30
Capital Growth
19 72 71 23
Stock Returns
57 67 77 87
Growth
75 31 57 21
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
49 41 30 50
Refinancing
67 42 55 41
Liquidity
80 78 85 94
Safety Safety
91 57 60 87

Similar Stocks

Discover high‑ranked alternatives to Innoviva and broaden your portfolio horizons.

Micron

NasdaqGS:MU
Country: USA
Industry: Semiconductors
Size: X-Large
Full Stock Analysis

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Alphabet

NasdaqGS:GOOG.L
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Lithia Motors

NYSE:LAD
Country: USA
Industry: Automotive Retail
Size: X-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.